# Traumatic hemipelvectomy: an appeal for primary completion

## TL;DR

Traumatic hemipelvectomy is a severe pelvic injury requiring immediate and aggressive treatment, with primary completion recommended in certain cases to improve outcomes.

## Contribution

The paper advocates for primary completion of traumatic hemipelvectomy in specific critical cases to reduce complications.

## Key findings

- Aggressive initial treatment with damage-control procedures is crucial for managing traumatic hemipelvectomy.
- Primary completion of TH is recommended over limb salvage in cases of critical ischemia and sacral nerve injury.
- Current literature mainly focuses on survivors, with limited treatment guidance for TH patients.

## Abstract

Traumatic hemipelvectomy (TH) is a rare and extremely severe injury of the pelvic area, which is often life-threatening and associated with a high mortality rate. Individual treatment is focused on the pelvic fracture and the type of accompanying injuries. The management of these severely injured patients places a considerable challenge on the resuscitation team. Patient management should be aggressive from the start. Current literature is focused predominantly on survivors, with only few case series providing possible treatment recommendations. Aggressive initial treatment is focused on standardized damage-control procedures during the prehospital, emergency room, and initial surgical phase to prevent exsanguination and contamination; a massive transfusion protocol should also be initiated immediately to address traumatic coagulopathy. Standard vascular treatment addresses the vascular injury. Colostomy is often recommended for adequate soft-tissue trauma management. Attempts at limb salvage often result in higher complications rates with non-functional limbs compared with completion of the TH. Thus, in cases of critical ischemia and identified relevant sacral nervous plexus injury during initial debridement in predominantly open injuries, primary completion of the hemipelvectomy is recommended. Level of Evidence: IV.